Predictions
CTS Eventim AG & Co. KGaA
Start price
Target price
Perf. (%)
€54.40
12.07.21
12.07.21
-
12.07.22
12.07.22
5.07%
13.03.22
13.03.22
Qingdao Haier Co., Ltd
Start price
Target price
Perf. (%)
€1.67
12.07.21
12.07.21
-
12.07.22
12.07.22
-25.14%
13.03.22
13.03.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€12.15
12.07.21
12.07.21
-
12.07.22
12.07.22
0.49%
13.03.22
13.03.22
Rubis S.A.
Start price
Target price
Perf. (%)
€36.74
12.07.21
12.07.21
€40.00
12.07.22
12.07.22
-38.95%
13.07.22
13.07.22
Could be worthwhile Investment >10% per year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€28.25
12.07.21
12.07.21
-
12.07.22
12.07.22
-48.20%
15.07.21
15.07.21
Risky Investment
NRX Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.05
12.07.21
12.07.21
€15.00
12.07.22
12.07.22
86.43%
23.07.21
23.07.21
Capable Management
Could be worthwhile Investment >10% per year
Innovative
Few uniques
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€6.22
12.07.21
12.07.21
€9.00
12.07.22
12.07.22
-22.46%
24.07.21
24.07.21
Could be worthwhile Investment >10% per year
Good culture
Below average Marketposition
Few uniques
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.42
12.07.21
12.07.21
-
12.07.22
12.07.22
-92.41%
13.07.22
13.07.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Autodesk Inc.
Start price
Target price
Perf. (%)
€251.70
12.07.21
12.07.21
-
12.07.22
12.07.22
-15.95%
08.02.22
08.02.22
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Valuable balance sheet
Standard Investments for future growth
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.61
12.07.21
12.07.21
€25.00
12.07.22
12.07.22
-50.33%
13.07.21
13.07.21
Capable Management
Good culture
No Innovation
Risky Investment
Alibaba Group Holding Ltd ADR
Start price
Target price
Perf. (%)
€172.60
12.07.21
12.07.21
€200.00
12.07.22
12.07.22
-55.74%
13.03.22
13.03.22
Could be worthwhile Investment >10% per year
Cemtrex Inc.
Start price
Target price
Perf. (%)
€63.35
12.07.21
12.07.21
€70.00
12.07.22
12.07.22
-39.78%
24.07.21
24.07.21
Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
Palantir Technologies Inc.
Start price
Target price
Perf. (%)
€19.55
12.07.21
12.07.21
-
12.07.22
12.07.22
-45.53%
13.03.22
13.03.22
Could be very worthwhile Investment >20% year
Very capable Management
Leading role in innovation
Very Future proof/growth oriented business model
Odonate Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.98
12.07.21
12.07.21
€5.00
12.07.22
12.07.22
8.05%
24.07.21
24.07.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
NeXR Technologies SE
Start price
Target price
Perf. (%)
€3.45
12.07.21
12.07.21
-
12.07.22
12.07.22
-42.03%
23.01.22
23.01.22
Business model of the past or high risk
Little known brand
Significant cyclical dependencies
Below average Marketposition
BioNTech SE ADR
Start price
Target price
Perf. (%)
€183.05
12.07.21
12.07.21
€111.00
12.07.22
12.07.22
-10.68%
13.07.22
13.07.22
Top 10 in its market
Known brand
Future proof or reliable business model
EBIT decline > 20% expected
Curevac N.V.
Start price
Target price
Perf. (%)
€49.65
12.07.21
12.07.21
€1.00
12.07.22
12.07.22
-73.61%
13.07.22
13.07.22
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Lululemon Athletica Inc.
Start price
Target price
Perf. (%)
€319.10
12.07.21
12.07.21
-
12.07.22
12.07.22
-12.25%
12.07.22
12.07.22
